title: 2013 ACC/AHA Guideline: a guideline for the population - without evidence from the population.
authors.affiliation: Center for Cardiovascular Disease Prevention of Mount Sinai, St. Luke's and Roosevelt Hospitals, New York, NY, USA, myersonm@optonline.net.
authors.forename: Merle
authors.initials: M
authors.lastname: Myerson
authors.forename: Robert S
authors.initials: RS
authors.lastname: Rosenson
mesh_terms: D000572:American Heart Association / Q000458:organization & administration*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000517:prevention & control*; D002309:Cardiology / Q000458:organization & administration*; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D003324:Coronary Artery Disease / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy*
chemical_list: D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors